NEUROONE MEDICAL TECHNOLOGIE
NMTCNASDAQTrading Snapshot
- Day Range
- $1.08 – $1.10
- 52-Week Range
- $1.28 – $6.96
- Volume
- $7.15B
- Avg Volume
- $6.15B
- Shares Outstanding
- 8.7M
- Next Earnings
- Nov 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $12M
- Last Q Revenue
- $2M
- P/E Ratio
- —
- P/S Ratio
- 1.2x
- EPS (TTM)
- $-0.84
- Dividend Yield
- —
- Dilution (1yr)
- +63.0%
Why Investors Own NMTC
- ✓High-growth profile — revenue up +40.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 49% gross margin and 20% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
NEUROONE MEDICAL TECHNOLOGIE
NMTC
StockOtter · stockotter.spaceAbout NEUROONE MEDICAL TECHNOLOGIE
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Analysts Set NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Price Target at $7.33
Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have earned a consensus recommendation of "Hold" from the five research firms that are presently covering the company, MarketBeat repor
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
EDEN PRAIRIE, Minn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on transforming the surgical diagnosis
$6 Million in New Markets Tax Credit Financing for the Acquisition, Renovation, and Equipping of a Tractor Assembly Facility in Monroeville, AL
$6 Million in New Markets Tax Credit Financing for the Acquisition, Renovation, and Equipping of a Tractor Assembly Facility in Monroeville, AL
NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript